LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for pharmaceutical discovery and development, today announced that John DiBella ,Vice President of Marketing and Sales, will present at the LD Micro Conference at 9:00 a.m. PST, Track 5, on Wednesday, December 2, 2015. The conference will be held December 1-3, 2015 at the Luxe Sunset Boulevard Hotel, 11461 Sunset Boulevard in Los Angeles. The Company’s group presentation will be available for the public to access at http://wsw.com/webcast/ldmicro9/slp. This webcast will be archived for 90 days following the live presentation. Simulations Plus management will be available during the day on Dec. 2, for one-on-one meetings. Please contact LD Micro to schedule a meeting.
For more information about the LD Micro Conference, visit www.ldmicro.com.
In addition, the Company also announced that Mr. DiBella will attend The Benchmark Company, LLC’s Micro Cap Discovery One-on-One Conference on Thursday, December 10, 2015. The conference will be held at The Palmer House Hilton, 17 E. Monroe Street, Chicago, from 8:00 a.m. to 2:30 p.m. CST. Please contact your Benchmark representative to schedule a one-on-one meeting.
For more information about The Benchmark Company, LLC’s Micro Cap Discovery Conference, visit http://www.benchmarkcompany.com/conference.php.
About LD Micro
LD Micro is an investment newsletter firm that focuses on finding undervalued companies in the microcap space. Since 2002, the firm has published reports on select companies throughout the year. The firm also hosts the LD Micro Invitational. It is a nonregistered investment advisor. For more information, please contact 408-457-1042 or visit www.ldmicro.com.
About The Benchmark Company LLC
Headquartered in New York with 11 offices coast to coast, The Benchmark Company, LLC is an institutional brokerage firm that provides research, sales, trading, and investment banking services to public companies and their investors.
About Simulations Plus, Inc.
Simulations Plus, Inc. is a premier developer of drug discovery and development software as well as a leading provider of both preclinical and clinical pharmacometric consulting services for regulatory submissions. The company is a global leader focused on improving the ways scientists use knowledge and data to predict the properties and outcomes of pharmaceutical and biotechnology agents. Our software is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies and regulatory agencies worldwide. Our innovations in integrating new and existing science in medicinal chemistry, computational chemistry, pharmaceutical science, biology, and physiology into our software have made us the leading software provider for physiologically based pharmacokinetic modeling and simulation. For more information, visit our website at www.simulations-plus.com.
Follow Us on Twitter